Cargando…

Dupuytren’s disease and the risk of malignant neoplasms

The object of this study was the investigation of the risk of occurrence of malignant neoplasms in 508 patients with Dupuytren’s disease (DD) and in 2157 of their 1st degree relatives. In the first stage of the study, we evaluated the tumour spectrum as well as the age of the patient at diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Żyluk, Andrzej, Paszkowska-Szczur, Katarzyna, Gupta, Satish, Scott, Rodney J, Lubiński, Jan, Dębniak, Tadeusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973858/ https://www.ncbi.nlm.nih.gov/pubmed/24598251 http://dx.doi.org/10.1186/1897-4287-12-6

Ejemplares similares

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
por: Dębniak, Tadeusz, et al.
Publicado: (2015)

Psoriasis vulgaris and familial cancer risk- a population-based study
por: Maleszka, Romuald, et al.
Publicado: (2013)

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population
por: Paszkowska-Szczur, Katarzyna, et al.
Publicado: (2014)

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population
por: Dębniak, Tadeusz, et al.
Publicado: (2018)

Principles of genetic predisposition to malignancies
por: Dębniak, Tadeusz, et al.
Publicado: (2008)

Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland
por: Dębniak, Tadeusz, et al.
Publicado: (2019)

Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk
por: Dębniak, T., et al.
Publicado: (2013)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012)

Familial Malignant Melanoma - Overview
por: Dębniak, Tadeusz
Publicado: (2004)

Paediatric Dupuytren's disease
por: Korambayil, Pradeoth Mukundan, et al.
Publicado: (2011)

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2018)

Microelements as risk factors for cancer of the lung and larynx
por: Jaworska-Bieniek, Katrzyna, et al.
Publicado: (2012)

Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
por: Zhou, Chaoming, et al.
Publicado: (2016)

Sorafenib in Dupuytren and Ledderhose Disease
por: Schoenfeld, Joshua D, et al.
Publicado: (2022)

Some Molecular and Clinical Aspects of Genetic Predisposition to Malignant Melanoma and Tumours of Various Site of Origin
por: Dębniak, Tadeusz
Publicado: (2007)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013)

Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012)

Ignore fractures of the ulnar styloid in distal radius fractures
por: Zyluk, Andrzej
Publicado: (2015)

Dupuytren's Disease: Review of the Current Literature
por: Khashan, Morsi, et al.
Publicado: (2011)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Dupuytren's Disease: the Vikings Disease in Koreans
por: Gong, Hyun Sik
Publicado: (2018)

Matrix and cell phenotype differences in Dupuytren’s disease
por: van Beuge, Marike M., et al.
Publicado: (2016)

Dupuytren's: a systems biology disease
por: Rehman, Samrina, et al.
Publicado: (2011)

Dutch Multidisciplinary Guideline on Dupuytren Disease
por: Kemler, Marius A., et al.
Publicado: (2022)

The Rationale for Treating the Nodule in Dupuytren’s Disease
por: Ketchum, Lynn D.
Publicado: (2015)

Epidemiological analysis of patients with Dupuytren's disease()
por: Mansur, Henrique Gonçalves, et al.
Publicado: (2017)

Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019)

Surgical treatment results for dupuytren's disease
por: Aykut, Serkan, et al.
Publicado: (2017)

EPIDEMIOLOGICAL ASPECTS OF DUPUYTREN'S DISEASE IN BRAZIL
por: Nakamoto, Hugo Alberto, et al.
Publicado: (2022)

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2020)

Dupuytren's Treatment of Scrofula
Publicado: (1830)

Dupuytren's Contraction and Dysparathyreoidism
Publicado: (1932)

Dupuytren’s Contraction of the Fingers
Publicado: (1882)

Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer
por: Miao, Beiping, et al.
Publicado: (2022)

Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals
por: Ågren, Richard, et al.
Publicado: (2023)

Developing an animal model of Dupuytren’s disease by orthotopic transplantation of human fibroblasts into athymic rat
por: Satish, Latha, et al.
Publicado: (2015)

Statistical and histological analysis of tumors of the upper extremity
por: Zyluk, Andrzej, et al.
Publicado: (2015)

Dupuytren's disease in bosnia and herzegovina. An epidemiological study
por: Zerajic, Dragan, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_9q2ffo2s0msn4dc07teinu1d9i